Indices of skeletal dynamics through week 52 of the PaTHway trial suggest that TransCon PTH augments the turnover of bone in a low turnover state and mobilizes calcium from the abnormally dense skeleton of adults with hypoparathyroidism. The gene discussed is PTH; the disease is hypoparathyroidism.